Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Stage IV Breast Cancer|Recurrent Breast Cancer
Interventions: DRUG: antineoplaston A10|DRUG: methotrexate|PROCEDURE: alternative product therapy|PROCEDURE: biological therapy|PROCEDURE: biologically based therapies|PROCEDURE: cancer prevention intervention|PROCEDURE: chemotherapy|PROCEDURE: complementary and alternative therapy|PROCEDURE: differentiation therapy
Sponsor: Burzynski Research Institute